• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Stakeholders call for collaboration to combat malnutrition in Nigeria
  • WaterAid, Cummins inaugurate WASH facilities at Lagos school
  • Kwara revitalises 100 primary healthcare facilities across state
  • REAN, NEMSA sign MoU to strengthen renewable energy compliance, safety
  • GovGuide Nigeria: AI Chatbot launched to improve access to govt services
  • Meta: Platforms contribute $820m annually to Nigeria’s economy
  • Wamakko hails Aliyu’s performance, backs APC’s 2027 governorship ticket
  • Hyperscalers bypassing Nigeria over high costs, outdated rules
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    FG, NDDC distribute support to 630 beneficiaries in Cross River

    May 21, 2026

    Olam Agri unveils Mama’s choice wheat flour, Mama’s pride semolina

    May 20, 2026

    Association secures N1.6bn support for onion farmers

    May 20, 2026

    IFAD trains 697 young farmers in Ondo

    May 20, 2026

    Experts advocate biotech solutions to cut Nigeria’s post-harvest losses

    May 20, 2026
  • Sci & Tech

    GovGuide Nigeria: AI Chatbot launched to improve access to govt services

    May 22, 2026

    Meta: Platforms contribute $820m annually to Nigeria’s economy

    May 21, 2026

    Hyperscalers bypassing Nigeria over high costs, outdated rules

    May 21, 2026

    Africa faces “year of reckoning” in 2026 as climate, food and health pressures converge — Report

    May 21, 2026

    Sokoto upgrades, renames College after Wamakko, expands programmes to HND level

    May 20, 2026
  • Health

    Kwara revitalises 100 primary healthcare facilities across state

    May 22, 2026

    Association celebrates 80 years with new projects, exhibits

    May 21, 2026

    Anambra offers free blood pressure checks

    May 21, 2026

    NYSC DG urges corps members to save, build multiple income streams

    May 21, 2026

    NYSC partners with NIMC to simplify biometric verification

    May 21, 2026
  • Environment

    WaterAid, Cummins inaugurate WASH facilities at Lagos school

    May 22, 2026

    Shettima reaffirms stronger Nigeria-Poland partnership

    May 21, 2026

    Lagos spends N3.99m on healthcare support for vulnerable residents

    May 21, 2026

    Lagos strengthens justice system with major infrastructure Investments

    May 21, 2026

    Nigeria achieves fully paperless Federal civil service

    May 20, 2026
  • Hausa News

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025

    [BIDIYO] Yadda na lashe gasa ta duniya a fannin Ingilishi – Rukayya ‘yar shekara 17

    August 6, 2025

    A Saka Baki, A Sasanta Saɓani Tsakanin ‘Yanjarida Da Liman, Daga Muhammad Sajo

    May 21, 2025

    Dan majalisa ya raba kayan miliyoyi a Funtuwa da Dandume

    March 18, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Stakeholders call for collaboration to combat malnutrition in Nigeria

    May 22, 2026

    WaterAid, Cummins inaugurate WASH facilities at Lagos school

    May 22, 2026

    Kwara revitalises 100 primary healthcare facilities across state

    May 22, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Stakeholders call for collaboration to combat malnutrition in Nigeria

    May 22, 2026

    WaterAid, Cummins inaugurate WASH facilities at Lagos school

    May 22, 2026

    Kwara revitalises 100 primary healthcare facilities across state

    May 22, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»Migraine-preventing drug significantly reduces rebound headache occurrence
Health & Healthy Living

Migraine-preventing drug significantly reduces rebound headache occurrence

Abdallah el-KurebeBy Abdallah el-KurebeOctober 7, 2024No Comments5 Mins Read
Migraine-prevention drug
Share
Facebook Twitter LinkedIn Pinterest Email

A drug used in the prevention of migraine may also help reduce so-called rebound headaches, according to a new review of data from a randomized, double-blind, placebo-controlled migraine trial.

  • A preventive drug for migraine proves effective at avoiding ‘rebound’ headaches in a new study.
  • The medication is sufficiently effective that people taking it have less need for additional pain meds that can cause rebound headaches.
  • The drug, atogepant, relaxes the blood vessel at which a migraine attack begins, preventing it from becoming too large and irritating the meninges at the bottom of the skull, causing the throbbing pain associated with migraine.

When the drug, atogepant, is taken every day, migraine-related pain can be alleviated, decreasing the need for additional painkillers, believed to be the source of rebound headaches.

The study was led by headache specialist Peter J. Goadsby, MBBS, MD, PhD of King’s College London in the United Kingdom, and a member of the American Academy of Neurology. Its findings appear in the journal Neurology.

Atogepant reduces rebound headaches by 50%

There were 755 participants in the trial, each of whom experienced chronic migraine. Each had at least 15 days of headaches per month, with at least eight qualifying as migraine.

Out of the total group, 66% were overusing pain medications, which often occurs with people attempting to get rid of their headaches.

They were resorting to simple analgesics — such as aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), or acetaminophen — for at least 15 days each month. Some took triptans or ergot alkaloids for at least 10 days. Some took a combination of both for at least 10 days in a month.

The trial began with a 4-week screening/baseline period.

At the beginning of the trial, participants averaged 18 to 19 migraine days per month and were taking medications for pain for 15 to 16 days.

Next, individuals were randomly assigned to take 30 milligrams (mg) of atogepant twice daily, 60 mg of atogepant once each day, or a placebo for 12 weeks. During this period, they were monitored for the frequency of their painkiller use.

Participants who took atogepant took painkillers on fewer days during the trial. Additionally, a higher proportion of participants taking atogepant had a 50% or greater reduction in rebound headaches per month.

What causes migraine and why it’s challenging to treat

In general, said Goadsby, “[m]igraine is an inherited brain disease whose attacks are triggered by changes in the brain and changes in the external environment.”

“We know the path of physiology, but we don’t know what causes a migraine because there are different triggers for different people,” Clifford Segil, DO, a neurologist at Providence Saint John’s Health Center in Santa Monica, CA, who was not involved in the study, told Medical News Today.

“For example,” he said, “many people with red wines versus white wines get it. Many people with cheeses get it. Caffeine both triggers headaches and treats headaches. So we’re still not entirely sure what causes the headaches.”

Modern, pharmaceutical therapies for migraine attacks fall into two camps: preventive and rescue. Atogepant is strictly a preventive drug, though it is closely related to two other drugs — ubrogepant and rimegepant — that are rescue and combination preventive/rescue drugs, respectively.

“Atogepant is a migraine preventive,” said Goadsby. “By taking it every day, the patient has less migraine and a much-reduced need for acute treatments such as painkillers. In effect, it stops the attack before it starts.”

The drug “relaxes the [involved] blood vessel, which makes it get narrower and not as wide, and when it’s not as wide, it feels better,” Segil explained.

What are rebound headaches?

Goadsby also explained rebound headaches and why they occur. He told us that:

“Rebound headache occurs when a medicine taken to relieve an attack wears off and the headache returns. Say you have a migraine that is going to last 2 days. If you take a medicine on day one that lasts for 24 hours, then the headache will return (rebound) the next day, and you need to take another treatment.”

“A big problem with migraines is that people take too much medication, so we can get what’s called a ‘medication overuse headache’ or a ‘rebound’ headache. The easiest example is when someone has some pain, and they take a Motrin, Advil, or Alleve [or some other] NSAID every day,” Segil explained.

Goadsby also cautioned that some pain medications, such as NSAIDs, taken too often, can result in stomach ulcers and other assaults on the digestive tract.

“Taking pain medicines can, paradoxically, increase the number of migraine days the patient has so-called medication overuse headache, so taking fewer pain meds stops that happening,” he said.

According to Segil, overuse of pain meds may never give a migraine attack a chance to go away.

Migraine symptoms: What to know

A migraine is a severe headache that is classically characterized by throbbing pain, sometimes covering half the head.

It may be accompanied by an uncomfortable sensitivity to bright lights and loud noises — photophobia or phonophobia, respectively — with or without blurry vision or a visual aura, a difficult-to-describe symptom in which vision becomes prismatic.

“Generally speaking, when people get migraines, there is a blood vessel between the brain and the skull in your meninges, and when the blood vessel gets too big, it dilates. It tugs on the meninges [which is] the shock absorber of the brain. That usually causes the throbbing pain,” Segil explained.

“After that, there’s irritation of the cortex of the brain, and a wave of electricity called cortical spreading depression, and that’s usually the radiating pain,” he detailed.

By Robby Berman, MedicalNewsToday

Migraine-preventing drug
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Abdallah el-Kurebe
  • Website
  • Facebook
  • Twitter
  • LinkedIn

Related Posts

Kwara revitalises 100 primary healthcare facilities across state

May 22, 2026

Association celebrates 80 years with new projects, exhibits

May 21, 2026

Anambra offers free blood pressure checks

May 21, 2026

Leave A Reply Cancel Reply

Stakeholders call for collaboration to combat malnutrition in Nigeria

May 22, 2026

WaterAid, Cummins inaugurate WASH facilities at Lagos school

May 22, 2026

Kwara revitalises 100 primary healthcare facilities across state

May 22, 2026

REAN, NEMSA sign MoU to strengthen renewable energy compliance, safety

May 22, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.